Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment

Oral Oncology

Volumn 48, Issue 9, 2012, Pages 787-793

  Haigentz Jr , Missak ^a   Hartl, Dana M ^b,c   Silver, Carl E ^a   Langendijk, Johannes A ^d   Strojan, Primož ^e   Paleri, Vinidh ^f   De Bree, Remco ^g   MacHiels, Jean Pascal ^h   Hamoir, Marc ^h   Rinaldo, Alessandra ⁱ   Paccagnella, Daniela ^j   Shaha, Ashok R ^k   Takes, Robert P ^l   Ferlito, Alfio ⁱ  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Laboratoire de Phonetique et de Phonologie   (France)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e INSTITUTE OF ONCOLOGY   (Slovenia)

^f NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ UNIVERSITY OF UDINE   (Italy)

^j S ANTONIO HOSPITAL   (Italy)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Chemotherapy; Distant metastases; Head and neck squamous cell carcinoma; Metastasectomy; Treatment

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; PANITUMUMAB;

BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LIVER METASTASIS; LONG TERM SURVIVAL; LUNG METASTASIS; METASTASIS RESECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SKIN METASTASIS;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM METASTASIS; SURVIVAL RATE;

EID: 84865174102     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.03.019     Document Type: Review

References (63)

1. X. Léon, M. Quer, C. Orús, M. del Prado Venegas, and M. López Distant metastases in head and neck cancer patients who achieved loco-regional control Head Neck 22 2000 680 686
2. J. Brouwer, R. de Bree, and O.S. Hoekstra Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient? Laryngoscope 115 2005 1813 1817 (Pubitemid 41475895)
3. S.K. Haerle, D.T. Schmid, N. Ahmad, T.F. Hany, and S.J. Stoeckli The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma Oral Oncol 47 2011 653 659
4. F.L. Ampil, D.D. Kim, G.E. Ghali, and R.G. Baluna How intensive should radiotherapy for head and neck cancer with synchronous distant metastases be? Review of cases J Oral Maxillofac Surg 70 2012 730 733
5. T.M. Mazer, K.T. Robbins, M.J. McMurtrey, and R.M. Byers Resection of pulmonary metastases from squamous carcinoma of the head and neck Am J Surg 156 1988 238 242
6. R.K. Finley 3rd, G.T. Verazin, and D.L. Driscoll Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck Am J Surg 164 1992 594 598
7. J. Wedman, A.J. Balm, and A.A. Hart Value of resection of pulmonary metastases in head and neck cancer patients Head Neck 18 1996 311 316 (Pubitemid 26177704)
8. D. Liu, D.M. Labow, and N. Dang Pulmonary metastasectomy for head and neck cancers Ann Surg Oncol 6 1999 572 578 (Pubitemid 29428797)
9. H. Winter, G. Meimarakis, and G. Hoffmann Does surgical resection of pulmonary metastases of head and neck cancer improve survival? Ann Surg Oncol 15 2008 2915 2926
10. F. Chen, M. Sonobe, and K. Sato Pulmonary resection for metastatic head and neck cancer World J Surg 32 2008 1657 1662
11. S. Shiono, M. Kawamura, and T. Sato Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas Ann Thorac Surg 88 2009 856 860
12. T. Mochizuki, S. Okumura, and G. Ishii Surgical resection for oral tongue cancer pulmonary metastases Interact Cardiovasc Thorac Surg 11 2010 56 59
13. Lin JC, Wiechmann RJ, Szwerc MF, et al. Diagnostic and therapeutic video-assisted thoracic surgery resection of pulmonary metastases. Surgery 1999;126:636-41. [discussion 641-2].
14. S. Saisho, M. Nakata, and S. Sawada Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience Surg Endosc 23 2009 55 61
15. S.S. Lo, A.J. Fakiris, and E.L. Chang Stereotactic body radiation therapy: a novel treatment modality Nat Rev Clin Oncol 7 2010 44 54
16. Y. Norihisa, Y. Nagata, and K. Takayama Stereotactic body radiotherapy for oligometastatic lung tumors Int J Radiat Oncol Biol Phys 72 2008 398 403
17. H. Hauswald, C. Simon, S. Hecht, J. Debus, and K. Lindel Long-term outcome and patterns of failure in patients with advanced head and neck cancer Radiat Oncol 6 2011 70
18. S. Lutz, L. Berk, and E. Chang Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline Int J Radiat Oncol Biol Phys 79 2011 965 976
19. B.M. Tijink, R. De Bree, G.A. Van Dongen, and C.R. Leemans How we do it: chemo-electroporation in the head and neck for otherwise untreatable patients Clin Otolaryngol 31 2006 447 451 (Pubitemid 44511170)
20. G. Sersa, M. Cemazar, and M. Snoj Electrochemotherapy of tumours Curr Oncol 16 2009 34 35
21. M. Gargiulo, M. Moio, G. Monda, S. Parascandolo, and G. Cubicciotti Electrochemotherapy: actual considerations and clinical experience in head and neck cancers Ann Surg 251 2010 773
22. A. Karatzas, K. Katsanos, I. Maroulis, C. Kalogeropoulou, E. Tzorakoleftherakis, and D. Karnabatidis Multi-modality curative treatment of salivary gland cancer liver metastases with drug-eluting bead chemoembolization, radiofrequency ablation, and surgical resection: a case report J Med Case Reports 5 2011 416
23. C.C. Pan, P.H. Wu, and J.R. Yu Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation Eur J Radiol 81 2012 e473 e477
24. J. Palussire, A. Italiano, and E. Descat Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients Ann Surg Oncol 18 2011 3771 3777
25. M. Di Staso, L. Zugaro, and G.L. Gravina A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases Eur Radiol 21 2011 2004 2010
26. R.P. Owen, S.A. Khan, and A. Negassa Radiofrequency ablation of advanced head and neck cancer Arch Otolaryngol Head Neck Surg 137 2011 493 498
27. Livraghi T, Meloni F, Solbiati L, Zanus G. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol 2011 Aug 11. [Epub ahead of print].
28. P.D. Brown, A.L. Asher, and E. Farace Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed Int J Radiat Oncol Biol Phys 70 2008 1305 1309
29. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 47 1981 207 214 (Pubitemid 11167383)
30. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
31. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
32. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
33. J.B. Vermorken, E. Remenar, and C. van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704 (Pubitemid 350005151)
34. M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715 (Pubitemid 350005152)
35. F.C. Holsinger, M.S. Kies, and E.M. Diaz Jr Durable long-term remission with chemotherapy alone for stage II-IV laryngeal cancer J Clin Oncol 27 2009 1976 1982
36. F.C. Holsinger, H.Y. Lin, V. Bassot, and O. Laccourreye Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx Cancer 115 2009 3909 3918
37. M. Haigentz Jr, C.E. Silver, A. Rinaldo, and A. Ferlito Definitive chemotherapy: a new frontier in the fight against laryngeal cancer Eur Arch Otorhinolaryngol 267 2010 1 4
38. W.K. Hong, S. Schaefer, and B. Issell A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck Cancer 52 1983 206 210 (Pubitemid 13063158)
39. Liverpool Head and Neck Oncology Group. A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Br J Cancer 1990;61:311-5.
40. C. Jacobs, G. Lyman, and E. Velez-García A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck J Clin Oncol 10 1992 257 263
41. A.A. Forastiere, B. Metch, and D.E. Schuller Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a southwest oncology group study J Clin Oncol 10 1992 1245 1251
42. A.A. Forastiere, D. Shank, D. Neuberg, SGt Taylor, R.C. DeConti, and G. Adams Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an eastern cooperative oncology group trial (PA390) Cancer 82 1998 2270 2274 (Pubitemid 28240836)
43. G. Catimel, J. Verweij, and V. Mattijssen Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC early clinical trials group Ann Oncol 5 1994 533 537
44. M.K. Gibson, Y. Li, and B. Murphy Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the eastern cooperative oncology group J Clin Oncol 23 2005 3562 3567
45. A.A. Forastiere, T. Leong, and E. Rowinsky Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: eastern cooperative oncology group study E1393 J Clin Oncol 19 2001 1088 1095 (Pubitemid 32176285)
46. P. Schöffski, G. Catimel, and A.S. Planting Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC early clinical studies group Ann Oncol 10 1999 119 122 (Pubitemid 29090602)
47. B.S. Glisson, B.A. Murphy, G. Frenette, F.R. Khuri, and A.A. Forastiere Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck J Clin Oncol 20 2002 1593 1599 (Pubitemid 34260540)
48. D.M. Shin, B.S. Glisson, and F.R. Khuri Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma J Clin Oncol 16 1998 1325 1330 (Pubitemid 28175747)
49. D.M. Shin, F.R. Khuri, and B.S. Glisson Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma Cancer 91 2001 1316 1323 (Pubitemid 32267043)
50. J. Baselga, J.M. Trigo, and J. Bourhis Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck J Clin Oncol 23 2005 5568 5577
51. J.B. Vermorken, J. Trigo, and R. Hitt Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy J Clin Oncol 25 2007 2171 2177 (Pubitemid 46954639)
52. J.B. Vermorken, R. Mesía, and F. Rivera Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 2008 1116 1127
53. J.B. Vermorken, J. Stohlmacher, and I. Davidenko Primary efficacy and safety results of SPECTRUM, a phase 3 trial in patients (pts) with recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) receiving chemotherapy with or without panitumumab (PMAB) Ann Oncol 21 Suppl 8 2010 LBA26
54. J.P. Machiels, S. Subramanian, and A. Ruzsa Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial Lancet Oncol 12 2011 333 343
55. J. Kao, S. Packer, and H.L. Vu Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response Cancer 115 2009 3571 3580
56. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program. Cancer 1987;60:301-11.
57. E.E. Cohen, D.J. Haraf, and R. Kunnavakkam Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 28 2010 3336 3343
58. K.J. Harrington, A. Berrier, and M. Robinson Phase II study of oral lapatinib, a dual-tyrosine kinase inhibitor, combined with chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN) J Clin Oncol 28 Suppl 15 2010 abstr 5505
59. P.K. Borjesson, E.J. Postema, and R. de Bree Radioimmunodetection and radioimmunotherapy of head and neck cancer Oral Oncol 40 2004 761 772 (Pubitemid 39061090)
60. R. Mesía, F. Rivera, and A. Kawecki Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck Ann Oncol 21 2010 1967 1973
61. J.G. Buckley, A. Ferlito, A.R. Shaha, and A. Rinaldo The treatment of distant metastases in head and neck cancer - present and future ORL J Otorhinolaryngol Relat Spec 63 2001 259 264 (Pubitemid 32620181)
62. A. Argiris, D.J. Haraf, M.S. Kies, and E.E. Vokes Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure Oncologist 8 2003 350 360 (Pubitemid 36929720)
63. B. Brockstein, D.J. Haraf, and A.W. Rademaker Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience Ann Oncol 15 2004 1179 1186 (Pubitemid 39199304)